New Data on Subcutaneous Bortezomib

被引:1
|
作者
Moreau, Philippe [1 ]
Touzeau, Cyrille [1 ]
机构
[1] Univ Hosp, Dept Hematol, F-44093 Nantes, France
关键词
RELAPSED MULTIPLE-MYELOMA; INTRAVENOUS BORTEZOMIB; COMBINATION REGIMENS; INJECTION;
D O I
10.1159/000362639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:26 / 28
页数:3
相关论文
共 50 条
  • [21] BLOOD DISTRIBUTION OF SUBCUTANEOUS BORTEZOMIB AND ITS KINETICS IN MULTIPLE MYELOMA PATIENTS
    Osawa, Takashi
    Naito, Takafumi
    Mino, Yasuaki
    Kawakami, Junichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S89 - S89
  • [22] First Year Experience Of Subcutaneous Bortezomib Use In a University Teaching Hospital
    Adam, Jean-Philippe
    Lemieux-Blanchard, Emilie
    Lemieux, Bernard
    Letarte, Nathalie
    BLOOD, 2013, 122 (21)
  • [23] Self-Administration of Subcutaneous Bortezomib in the Home Setting: A Feasibility Study
    Jagger, Jacqui
    Parr, Emma
    King, Jennie
    Swab, Michael
    Cox, Brookie
    King, Tracy
    Acret, Louise
    Fuller, Erin
    White, Kate
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S285 - S285
  • [24] Subcutaneous bortezomib may be the better delivery method to treat multiple myeloma
    Wraight, Sophie
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (06) : 591 - 591
  • [25] AN EVALUATION OF THE INCIDENCE OF ADVERSE EVENTS BY SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF BORTEZOMIB
    Hisama, Shoko
    Nosaka, Kisato
    Yano, Yumiko
    Mori, Naomi
    Okamoto, Yasuko
    Okuno, Yutaka
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Improved Safety with the Use of Subcutaneous Bortezomib in Combination with Panobinostat and Dexamethasone: Preliminary Data from a Panobinostat Global Expanded Treatment Protocol
    Guenther, Andreas
    Mugge, Lars-Olof
    Haenel, Mathias
    Schjesvold, Fredrik H.
    Lechner, Daniel
    Yaser, Sameer
    Hebart, Holger
    Gisslinger, Heinz
    Greil, Richard
    Gunsilius, Eberhard
    Goerner, Martin
    Weisel, Katja
    Durig, Jan
    Elemary, Mohamed
    Wolleschak, Denise
    Klein, Stefan A.
    Munder, Markus
    Kiani, Alexander
    Nahi, Hareth
    Junghanss, Christian
    Campello-Iddison, Valerie
    Deniau, Ythier
    Feng, Xiaoshu
    Einsele, Hermann
    BLOOD, 2016, 128 (22)
  • [27] Efficacy and safety of subcutaneous bortezomib versus intravenous bortezomib in patients with multiple myeloma: a systematic review and meta-analysis
    Zhang, Shilong
    Li, Jing
    Liu, Peng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (02): : 445 - +
  • [28] Successful Transition from Bortezomib Subcutaneous (SubQ) to Generic Intravenous (IV) Bortezomib: Cost Savings Initiative with Global Economic Impact
    Jhaveri, Radhika
    Sanchorawala, Vaishali
    Sloan, John Mark
    Lerner, Adam
    Sarosiek, Shayna
    Shah, Bhavesh
    BLOOD, 2019, 134
  • [29] Subcutaneous injection of a bortezomib-loaded thermosensitive hydrogel for the treatment of multiple myeloma
    Qu, Ying
    Chu, Bingyang
    Shi, Kun
    Wei, Xue
    Yang, Peipei
    Chen, Mengran
    Tang, Minghai
    Li, Shiqian
    Wang, Fangfang
    Yang, Xijing
    Zheng, Yuhuan
    Niu, Ting
    Qian, Zhiyong
    CHEMICAL ENGINEERING JOURNAL, 2023, 455
  • [30] Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib
    Patel, Priyank P.
    Becker, Joanne
    Freyer, Craig
    Griffiths, Elizabeth
    Thompson, James E.
    Wang, Eunice S.
    TRANSFUSION, 2016, 56 (04) : 970 - 974